Prices and rates subtopic
| |
Articles
1-128 out of 128 article(s)
| Title |
Author |
Type |
Date |
Words |
| Canada : Quebec exports restrained by weak mineral prices - EDC forecast. |
|
|
Nov 23, 2012 |
501 |
| Confidential Pricing Agreements Mitigate the Risks of Low Drug Prices in Key Markets. |
|
|
Oct 16, 2012 |
443 |
| Research and Markets: United Arab Emirates Pharmaceutical and Healthcare Report Q3 2012: Prices for Tests Such as Blood Tests, X-Rays, MRI Scans and CAT Scans Will Decrease by 24%. |
|
Report |
Aug 20, 2012 |
543 |
| Pharmaceutical officials head to Greece to compare drug prices. |
|
|
Apr 4, 2012 |
263 |
| The Outlook for Pharmaceuticals in Brazil, Russia, India & China. |
|
|
Jul 12, 2011 |
1760 |
| Abbott pays $126M settlement; Justice Dept. alleges three drug companies inflated prices. |
|
|
Dec 8, 2010 |
356 |
| The Lipitor loophole. |
Peters, Charles |
Brief article |
Nov 1, 2010 |
182 |
| Should the Kefauver-Harris Amendment be repealed? |
Gaby, Alan R. |
Editorial |
Aug 1, 2010 |
785 |
| Pill sales popping: in the space of four weeks this year, diet drug sensation Alli tripled the value of the weight management market and boosted the fortunes of other slimming pills--but is it just a flash in the pan. |
Relf, Cathy |
Industry overview |
Nov 28, 2009 |
1143 |
| GlaxoSmithKline Plc sealed a deal with Brazil guaranteeing sales of its pneumococcal vaccine for 10 years, the company said. |
|
Brief article |
Oct 5, 2009 |
178 |
| Research and Markets: Between 2009 and 2014, Peru's Annual Growth in Pharmaceutical Expenditure at Retail Prices is Expected to Be 5%. |
|
|
Sep 30, 2009 |
461 |
| The generic drug rip off. |
Faloon, William |
|
Aug 1, 2009 |
3952 |
| Animal drug industry growing. |
|
Statistical data |
Aug 1, 2009 |
2041 |
| Biotech drug copies could be held up 13 years under Senate plan. |
|
|
Jul 13, 2009 |
366 |
| Average wholesale price increase, top 10 Rx brands. |
|
Statistical table |
Jul 1, 2009 |
82 |
| Weekly key rates. |
|
Brief article |
Jun 15, 2009 |
110 |
| In other news, competition for the Botox shot, America's most popular cosmetic procedure, was delayed as FDA staff discuss labeling and a strategy for evaluating and mitigating risks of the new wrinkle smoother. |
|
Brief article |
Apr 20, 2009 |
163 |
| ICCI asks govt to encourage domestic pharmaceutical industry. |
|
|
Apr 17, 2009 |
416 |
| Medicine prices will not increase, says Health Ministry. |
|
|
Jan 22, 2009 |
359 |
| Roche reduces Tarceva price for UK cancer patients. |
|
Brief article |
Dec 1, 2008 |
259 |
| The United Kingdom has finalized a new drug pricing scheme that it says will cut costs to government while increasing the availability of medicines to patients. |
|
Brief article |
Nov 24, 2008 |
248 |
| Malaria drug pricing deal on cards. |
Bateman, Chris |
Brief article |
Nov 1, 2008 |
269 |
| 4 ways to control drug costs: by following new business strategies, no-fault auto insurers can manage rising medication prices. |
Scaggs-Oskoui, Lisa |
|
Oct 1, 2008 |
1352 |
| Prices of US Biotech drugs rise sharply in 2007. |
|
Brief article |
Sep 29, 2008 |
304 |
| Pfizer, Glaxo raise prices as drug growth declines. |
|
Brief article |
Mar 31, 2008 |
206 |
| Brand-name drugs continue sharp price increases. |
|
Brief article |
Mar 10, 2008 |
263 |
| Thin margins for community pharmacies. |
|
Brief article |
Mar 1, 2008 |
271 |
| Virile vaccine market sparks growth: Hedwig Kresse, Datamonitor's vaccines analyst, comments on the rapid growth in the vaccines market. |
Kresse, Hedwig |
Report |
Nov 1, 2007 |
1099 |
| Confidence builder: in both shelf and promotion price tags, accuracy is hugely important to maintaining consumer trust in your retail brand. |
Kiernan, Patrick |
|
Oct 1, 2007 |
871 |
| Reducing costs through outsoursing: Philippe Mougin, Managing Director, Cenexi, reviews the financial aspects of staying ahead in the competitive market of ampoule production, where outsourcing could be of great benefit. |
Mougin, Philippe |
|
Sep 1, 2007 |
1428 |
| Bentley Pharmaceuticals' quarterly profits dropped sharply as a result of the Spanish government's policy of cutting the cost of prescription medicine as well as increased operating costs, the company announced. |
|
Brief article |
Aug 17, 2007 |
97 |
| Grassley presses EPO makers on safety, pricing and marketing. |
|
|
Jun 18, 2007 |
504 |
| Zacks Analyst Blog Highlights: UAL Corporation, Akzo Nobel, Schering-Plough and D.R. Horton. |
|
|
Jun 15, 2007 |
777 |
| Costs grow for Medicare drugs. |
Anderson, Jane |
Brief article |
Jun 15, 2007 |
219 |
| Brazilian President Luiz Inacio Lula da Silva plans to break the patent on Merck & Co's (Whitehouse Station NJ) AIDS drug Efavirenz after the company's offer to cut prices failed to satisfy demands from the country's health ministry. |
|
Brief article |
May 7, 2007 |
143 |
| Merck & Co., Inc., Again Reduces Price of STOCRIN (efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic. |
|
|
Feb 14, 2007 |
1023 |
| Generic drugs keep health cost spiral in check. |
Ault, Alicia |
|
Feb 1, 2007 |
599 |
| Medicare Part D doughnut hole may not be worth filling. |
Finkelstein, Joel B. |
|
Feb 1, 2007 |
477 |
| Neurochem reports results for third quarter of fiscal 2006. |
|
|
Nov 8, 2006 |
4102 |
| Economics of the Pharmaceutical Industry. |
Danzon, Patricia M. |
|
Sep 22, 2006 |
2737 |
| Global competition and the United States pharmaceutical industry. |
Ramrattan, Lall; Szenberg, Michael |
Author abstract |
Sep 22, 2006 |
12465 |
| Prices soar for cancer drugs: slight increase in survival, vast increase in cost. |
Szabo, Liz |
|
Sep 1, 2006 |
750 |
| Zacks Bull and Bear of the Day Highlights: Intevac, Onyx Pharmaceuticals, EOG Resources and UAL Corporation. |
|
|
Aug 10, 2006 |
976 |
| AHF Calls Gilead's Plan to Cut AIDS Drug Prices in Middle-income Countries by Two-thirds 'Precedent-setting'. |
|
|
Jul 17, 2006 |
541 |
| Prices of generic medicines decline. |
|
Brief article |
Jul 1, 2006 |
104 |
| Meeting explores pricing of pharmaceutical products. |
|
|
Jun 1, 2006 |
872 |
| Zacks Top Simulator Player Interview features Micro Linear Corp., OMNI Energy Services Corp., Gold Fields Limited, Transmeta and Biopure Corp. |
|
|
Apr 27, 2006 |
903 |
| Prescription for disaster. |
Hoar, William P. |
|
Apr 3, 2006 |
160 |
| Scaring seniors over choices. |
Hoar, William P. |
Brief article |
Apr 3, 2006 |
294 |
| Japan. |
|
Brief Article |
Jan 31, 2006 |
203 |
| Experts divided on generic biologics. |
Frieden, Joyce |
|
Mar 15, 2005 |
708 |
| Industry backlash over cheaper drugs: faced with a rising demand for medical drugs from the country's poor, the government of South Africa put a clamp on the retail prices of medications--leading to a howl of protest from the pharmaceutical industry. The matter is now with the country's highest court. Tom Nevin reports. |
Nevin, Tom |
|
Feb 1, 2005 |
1390 |
| 1. Prices of 29 types of generic medicines reduced. |
|
|
Nov 30, 2004 |
1699 |
| Operating margins rise and SG&A spending increases. |
|
|
Sep 30, 2004 |
872 |
| Monopoly medicine: the built-in inefficiencies of a patent-based pharmaceutical R&D system. |
Love, James |
|
Jul 1, 2004 |
2719 |
| Price relative to competition: the case of the pharmaceutical industry in Spain. |
Arranz, Ana Maria G.; Cruz, Natalia M.; Escudero, Ana Isabel R. |
|
Jan 1, 2004 |
4375 |
| Germany. |
|
Brief Article |
Sep 15, 2003 |
101 |
| 483/EIR update. |
|
|
Sep 1, 2003 |
2010 |
| Generic drugs. The smart choice. |
Shoptaw, Robert L. |
Brief Article |
Aug 18, 2003 |
297 |
| New over-the-counter drugs: Claritin and Prilosec no longer prescription only. |
|
Brief Article |
Aug 18, 2003 |
310 |
| Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. |
Fischer, Michael A.; Avorn, Jerry |
Illustration |
Aug 1, 2003 |
4651 |
| Report raises concerns about overmedicating seniors. |
Edwards, Douglas J. |
|
Aug 1, 2003 |
338 |
| Prices of drug basic materials up 10%. |
|
Brief Article |
Jun 24, 2003 |
106 |
| Huge price variations in generic drugs. |
|
Author Abstract |
May 30, 2003 |
403 |
| CHEAPER AIDS DRUGS FOR REGION. |
|
Brief Article |
Mar 1, 2003 |
168 |
| Mail-order Rx firms broker cheap drugs. |
Leonard, Martha |
|
Jan 6, 2003 |
2120 |
| Shaking up the drug industry. (Trends). |
Batstone, David |
|
Jan 1, 2003 |
735 |
| Prescribing away drug R and D. (Correction, Please!). |
Hoar, William P. |
Brief Article |
Aug 26, 2002 |
268 |
| Stripping away Big Pharma's fig leaf. (Editorial). |
|
|
Jun 1, 2002 |
1306 |
| The war on drug--prices: States are taking up the fight to reduce prescription drug costs. |
Boulard, Garry |
|
Mar 1, 2002 |
5128 |
| Drug Pricing. |
|
|
Jan 25, 2002 |
319 |
| otc medicines. |
Hardcastle, Sarah |
|
Oct 13, 2001 |
2432 |
| From Ponce de Leon to Prescription Medications. |
Swift, Billie |
Brief Article |
Aug 1, 2001 |
696 |
| PHARMACEUTICAL BENEFITS IN AUSTRALIA AND SWEDEN: WELFARE POLICY AND THE COST OF PRESCRIPTION DRUGS. |
Lofgren, Hans |
|
Aug 1, 2001 |
5513 |
| Costs for Prescription Drugs Will Continue to Climb. |
Leonard, Bill |
Brief Article |
May 1, 2001 |
270 |
| Aids drugs deal. |
Williams, Stephen |
Brief Article |
Apr 1, 2001 |
132 |
| 'The profits that kill'. (Cover Story/Drugs). |
Boateng, Osei |
|
Apr 1, 2001 |
3353 |
| A Bitter Pill. |
Pilla, David |
Statistical Data Included |
Jan 1, 2001 |
1055 |
| Global Treatment Access: Call for 95% Price Reduction; New GTAC Organization, Web Site. |
|
Brief Article |
Dec 1, 2000 |
247 |
| Pfizer forum. |
Tabarrok, Alex |
Brief Article |
Dec 1, 2000 |
718 |
| Thabo Mbeki ignites AIDS inferno. |
Vesely, Milan |
|
Jun 1, 2000 |
1626 |
| Effect of multiple-source entry on price competition after patent expiration in the pharmaceutical industry. |
Suh, Dong-Churl; Manning, Willard G., Jr.; Schondelmeyer, Stephen; Hadsall, Ronald S. |
|
Jun 1, 2000 |
6495 |
| Drug-Industry Mergers Could Be Costly For HMOs. |
Thorsen, Eric |
Brief Article |
Mar 1, 2000 |
486 |
| Prescription Blackmail. |
Buell, John |
Brief Article |
Sep 1, 1999 |
807 |
| Medicine for the masses. |
Kimble-Ellis, Sonya |
Brief Article |
Jul 1, 1999 |
431 |
| IMS Forecasts Drug Prices Rose Under 2 Percent in 1996 |
|
|
Feb 13, 1997 |
345 |
| Public Information Campaign Targets High Drug Prices Charged By Tampa-based Pharmacy Corporation of America |
|
|
Nov 12, 1996 |
616 |
| DaunoXome therapy cuts cost of treating Kaposi's sarcoma. |
|
|
Jul 9, 1996 |
400 |
| NACDS: RATE OF INCREASE IN RETAIL DRUG PRICES DEMONSTRATES PRACTICE OF DISCRIMINATORY PRICING BY DRUG MANUFACTURERS |
|
|
Feb 16, 1996 |
448 |
| NACDS PRIME INDEX MEASURES 4.6% INCREASE IN PRICES OF TOP 500 PRESCRIPTION DRUGS DISPENSED IN COMMUNITY PHARMACIES, INCREASES ALSO FOUND BY U.S. DEPARTMENT OF LABOR'S BUREAU OF LABOR STATISTICS |
|
|
Feb 14, 1996 |
771 |
| NACDS STATEMENT REGARDING TENTATIVE SETTLEMENT IN LAWSUIT |
|
|
Jan 18, 1996 |
238 |
| NACDS PRIME INDEX REPORTS INCREASE IN PRICES FOR TOP 500 PRESCRIPTIONS DISPENSED IN COMMUNITY PHARMACIES |
|
|
Dec 7, 1995 |
566 |
| /C O R R E C T I O N -- Celgene Corp. Price of AIDS Drug Overstated/(Correction Notice) |
|
Correction Notice |
Oct 13, 1995 |
164 |
| FDA GRANTS CELGENE CORP. PERMISSION TO RECOVER COSTS OF THALIDOMIDE FOR AIDS WASTING TRIAL |
|
|
Oct 13, 1995 |
585 |
| INVESTIGATION REVEALS DISCRIMINATORY DRUG PRICING IN WISCONSIN |
|
|
Jul 31, 1995 |
640 |
| Merck & Co. makes announcement. |
|
|
Mar 15, 1995 |
318 |
| Lilly Announces Third Consecutive Year of Voluntary Price Constraints. |
|
|
Dec 22, 1994 |
398 |
| MANUFACTURERS' PRICES FOR TOP PRESCRIPTION DRUGS CONTINUE TO RISE, NACDS PRIME INDEX DOCUMENTS |
|
|
Dec 15, 1994 |
665 |
| LANDMARK COMMUNITY RETAIL PHARMACY LAWSUITS CHALLENGE ANTICOMPETITIVE, INFLATIONARY PRICING PRACTICES OF MAJOR PRESCRIPTION DRUG MANUFACTURERS |
|
|
Nov 30, 1994 |
784 |
| PHARMACEUTICAL FIRMS PROMOTING ANTI-COMPETITIVE MARKET AND FORCING HIGHER PRICES FOR CONSUMERS, NEW PRIME INSTITUTE STUDY CONCLUDES |
|
|
Aug 4, 1994 |
1086 |
| Rage against the cure: the health hazards of pharmaceutical price controls. |
Goldberg, Robert M. |
|
Mar 22, 1994 |
5811 |
| SCHERING-PLOUGH REPORTS PRICE REDUCTION OF INTRON A FOR HEPATITIS C IN JAPAN |
|
|
Mar 11, 1994 |
251 |
| Prescription drug industry must be reformed. |
Pryor, David |
|
Mar 1, 1994 |
1763 |
| PFIZER SAYS AVERAGE 1994 PRICE INCREASE WILL BE UNDER 2.5 PERCENT; NO INDIVIDUAL PRODUCT INCREASE WILL EXCEED 3.5 PERCENT |
|
|
Jan 17, 1994 |
277 |
| STERLING HEALTH USA ROLLS BACK PRICEFOR THREE GENUINE BAYER ASPIRIN PRODUCT SIZES |
|
|
Sep 22, 1993 |
290 |
| Pricing in the US pharmaceutical industry. |
Brendt, Ernst R.; Griliches, Zvi |
|
Jun 22, 1993 |
1820 |
| HOECHST-ROUSSEL PHARMACEUTICALS SETS NEW PRICING POLICY |
|
|
Jun 22, 1993 |
248 |
| LEDERLE EXTENDS PROSTEP REBATE THROUGH END OF YEAR TO MAKE PRESCRIPTION NICOTINE PATCH MORE ACCESSIBLE IN LIGHT OF FDA BAN ON OVER-THE-COUNTER SMOKING CESSATION AIDS |
|
|
Jun 4, 1993 |
975 |
| SYNTEX PLEDGES VOLUNTARY RESTRAINT ON PRESCRIPTION DRUG PRICE INCREASES |
|
|
Apr 12, 1993 |
428 |
| PFIZER: CHART IN NEW YORK TIMES OVERSTATES PRICE INCREASE FOR PFIZER'S PROCARDIA XL |
|
|
Mar 16, 1993 |
293 |
| SUMMARY HIGHLIGHTS OF THE TESTIMONY |
|
|
Feb 22, 1993 |
393 |
| THE DU PONT MERCK PHARMACEUTICAL COMPANY DISPUTES SENATE PRICING ALLEGATIONS |
|
|
Feb 3, 1993 |
866 |
| GLAXO'S OVERALL PRICE INCREASE FOR FISCAL 1992 AT 1.8 PERCENT |
|
|
Feb 3, 1993 |
376 |
| GERALD J. MOSSINGHOFF, PRESIDENT, PHARMACEUTICAL MANUFACTURERS ASSOCIATION, IN RESPONSE TO CHARGES BY SEN. PRYOR ON INDUSTRY PRICING |
|
|
Feb 3, 1993 |
507 |
| ICI PHARMACEUTICALS GROUP REAFFIRMS PRICE RESTRAINT POLICY FOR 1993 |
|
|
Feb 3, 1993 |
514 |
| WYETH-AYERST LABORATORIES RESPONDS TO SENATE AGING COMMITTEE REPORT |
|
|
Feb 3, 1993 |
575 |
| STATEMENT ON PFIZER 1992 PHARMACEUTICAL PRICE INCREASES |
|
|
Feb 2, 1993 |
343 |
| PFIZER SAYS AVERAGE PRICE INCREASE ON U.S. PHARMACEUTICALS TO BE UNDER 3 PERCENT FOR 1993 |
|
|
Jan 25, 1993 |
371 |
| STERLING WINTHROP CONTINUES COMMITMENT TO RESPONSIBLE PHARMACEUTICAL PRICING; WILL HOLD 1993 PRICING AT OR BELOW RATE OF INFLATION |
|
|
Dec 23, 1992 |
493 |
| ASTRA CUTS FOSCAVIR PRICE FOR AIDS PATIENTS IN FEDERALLY FUNDED PROGRAMS |
|
|
May 14, 1992 |
1398 |
| SANDOZ ANNOUNCES PRICE REDUCTION TO VETERANS ADMINISTRATION, PUBLIC HEALTH SERVICE AND OTHER FEDERAL CLINICS |
|
|
Mar 26, 1992 |
381 |
| BURROUGHS WELLCOME VOLUNTARILY REDUCES PRESCRIPTION DRUG PRICES TO FEDERALLY FUNDED PUBLIC HEALTH CLINICS AND GOVERNMENT AGENCIES USING FSS |
|
|
Feb 12, 1992 |
591 |
| ICI PHARMACEUTICALS WILL LIMIT PRICE ADJUSTMENTS TO INFLATION RATE |
|
|
Feb 3, 1992 |
352 |
| SEARLE ANNOUNCES SPECIFICS OF DISCOUNT PRICING TO PUBLIC HEALTH SERVICE CLINICS |
|
|
Feb 3, 1992 |
329 |
| ASTRA TO SUPPORT KENNEDY FEDERAL DRUG PRICE REBATE LEGISLATION; TO DEVELOP VOLUNTARY DISCOUNT PROGRAM ON NEW AIDS DRUG, OTHER PRODUCTS |
|
|
Jan 27, 1992 |
507 |
| BRISTOL-MYERS SQUIBB ANNOUNCES VOLUNTARY REDUCTION IN PHARMACEUTICAL PRICES TO FEDERAL GOVERNMENT |
|
|
Jan 7, 1992 |
420 |
| BRISTOL-MYERS SQUIBB ANNOUNCES VOLUNTARY REDUCTION IN PHARMACEUTICAL PRICES TO FEDERAL GOVERNMENT |
|
|
Jan 7, 1992 |
420 |
| Cost containment as a stimulative force. |
|
Panel Discussion |
Jan 1, 1992 |
3842 |
|
